FDA approves cancer gene detection kit for consumers

The FDA has given the go-ahead for genetic testing company 23 and Me to market their cancer gene detection kit directly to consumers. The kit is designed to help users identify three mutations linked to the common breast cancer gene, BRCA. Dr. Keri Peterson, an internist at Lenox Hill Hospital, further explains the kit, its possible shortcomings and how it could benefit populations at high risk for breast cancer.

Get the latest health news

Keep up-to-date on breaking health news with insights from our experts and developments from around the health system.